載入...

Identifying and targeting pathogenic PI3K/AKT/mTOR signaling in IL-6 blockade–refractory idiopathic multicentric Castleman disease

BACKGROUND: Idiopathic multicentric Castleman disease (iMCD) is a hematologic illness involving cytokine-induced lymphoproliferation, systemic inflammation, cytopenias, and life-threatening multi-organ dysfunction. The molecular underpinnings of interleukin-6 (IL-6) blockade–refractory patients rema...

全面介紹

Na minha lista:
書目詳細資料
發表在:J Clin Invest
Main Authors: Fajgenbaum, David C., Langan, Ruth-Anne, Japp, Alberto Sada, Partridge, Helen L., Pierson, Sheila K., Singh, Amrit, Arenas, Daniel J., Ruth, Jason R., Nabel, Christopher S., Stone, Katie, Okumura, Mariko, Schwarer, Anthony, Jose, Fábio Freire, Hamerschlak, Nelson, Wertheim, Gerald B., Jordan, Michael B., Cohen, Adam D., Krymskaya, Vera, Rubenstein, Arthur, Betts, Michael R., Kambayashi, Taku, van Rhee, Frits, Uldrick, Thomas S.
格式: Artigo
語言:Inglês
出版: American Society for Clinical Investigation 2019
主題:
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6763254/
https://ncbi.nlm.nih.gov/pubmed/31408438
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI126091
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!